Why the study?
Does clamped-warm storage extend the viability period of skeletal muscle for the malignant hyperthermia test to 24 hours in MHS patients?
Does clamped-warm storage extend the viability period of skeletal muscle for the malignant hyperthermia test to 24 hours in MHS patients?
Storing skeletal muscle samples under tension in Krebs buffer at 23°C–25°C extends their viability for malignant hyperthermia testing up to 24 hours, potentially allowing for interlaboratory sharing of control samples.
Answers are grounded in this paper and cite their sources.
May extend MH biopsy viability to 24 h in animal models; leaves open human translation and interlaboratory use.
The caffeine halothane contracture test (CHCT) is the only validated test for diagnosing malignant hyperthermia (MH) susceptibility (MHS) and phenotyping MHS families. Although most diagnostic laboratory tests can check intra- and interlaboratory consistency through the use of standard control samples, there has been no practical way to achieve this goal for the CHCT. The distances between diagnostic centers and time constraints of the CHCT protocol (5 h) prohibit centers from sharing tissue samples. In this study, we investigated varying storage conditions to extend the standard viability period of skeletal muscle to 24 h. Twenty MHS patients were tested according to the North America protocol. After standard CHCT, the surplus muscle samples were placed in one of the following four treatment groups. In Groups 1 and 2, muscles remained under tension and were stored in Krebs buffer (pH 7.4) at 23°C–25°C (clamped-warm) and 4°C (clamped-cold), respectively. In Groups 3 and 4, muscle strips were dissected, and the ends were tied with silk sutures, cut from the clamp, and placed in Krebs buffer at 23°C–25°C (free-warm) and 4°C (free-cold), respectively. The responses of the treatment groups to halothane (3%) and caffeine (0.5–32 mM) were tested at 22–26 h after excision. The clamped-warm storage group correctly diagnosed MHS in all patients.
No takes yet. Share an insight, caveat, or question.
Bina et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: